Frank Clyburn

Chief Executive Officer
International Flavors & Fragrances Inc.

Frank Clyburn has served as IFF’s Chief Executive Officer since February 2022.

Previously, he held the role of Executive Vice President and President of Human Health for Merck & Co. (Merck), where he had full P&L responsibility of their largest business. During his tenure, he was also responsible for building one of the leading oncology businesses in the world, which is the largest business within Merck and has transformed cancer care on a global scale.

Mr. Clyburn joined Merck in 2008 and held several positions including Chief Commercial Officer, the inaugural president of the company’s Global Oncology business, and President of its Primary Care and Women’s Health businesses. In addition to leading the creation of the Global Oncology business, Mr. Clyburn also executed the worldwide launch of Merck’s immuno-oncology medicine which helped establish the company as a leader in oncology.

Before joining Merck, Mr. Clyburn was Vice President of the Oncology and Internal Medicine business units at Sanofi Aventis and held a wide range of leadership roles with the company.  In addition, was actively involved in the $65 billion integration of Sanofi and Aventis.

Mr. Clyburn received his Master of Business Administration degree from Arizona State University and his Bachelor of Arts degree from Franklin & Marshall College. Notably, he served on the Board of Directors of DuPont from June 1, 2019 to January 20, 2022. He currently serves on the Board of Directors for the European Federation of Pharmaceutical Industries and Associations (EFPIA). He also served as chairman to the Thomas Edison State University Board of Trustees.